Stocks HUYA Financial statements
Financial statementsHUYA Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data HUYA Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 678 | 1,203 | 1,673 | 1,781 | 1,337 | 985 | 833 | 930 |
| Cost of revenue | 572 | 990 | 1,325 | 1,530 | 1,248 | 870 | 722 | 805 |
| Gross profit | 106 | 213 | 348 | 251 | 88.6 | 115 | 111 | 125 |
| Research and development | 38.6 | 73.1 | 113 | 129 | 98.6 | 81.5 | 70.2 | 71 |
| Selling and marketing | 27.5 | 63 | 85.5 | 119 | 70 | 62.1 | 37.5 | 38.1 |
| General and administrative | 41.8 | 50.7 | 68.2 | 51.3 | 46.5 | 45.2 | 34.9 | 44.2 |
| Operating expenses | 108 | 187 | 266 | 299 | 215 | 189 | 143 | 153 |
| Operating income | 3.88 | 37.5 | 111 | -4.73 | -102 | -62.5 | -26 | -23.2 |
| Interest income | 22.8 | 43.7 | 48 | 38.8 | 43.2 | 67.6 | 53.6 | 27.3 |
| Pre-tax income | -306 | 81.4 | 158 | 40.7 | -66.4 | -26.9 | -4.72 | -13.9 |
| Income tax | 8.67 | 4.04 | 1.86 | 1.85 | 1.83 | |||
| Net income | -282 | 67.2 | 136 | 91.6 | -70.6 | -28.8 | -6.57 | -16.1 |
| EBITDA | 7.78 | 44.1 | 120 | 3.09 | -96.1 | -55.9 | -20.5 | -18.2 |
| EPS, basic | -2.19 | 0.31 | 0.60 | 0.38 | -0.29 | -0.12 | -0.03 | -0.07 |
| EPS, diluted | -2.19 | 0.29 | 0.57 | 0.38 | -0.29 | -0.12 | -0.03 | -0.07 |
| Shares, basic (weighted) | 167 | 215 | 227 | 238 | 241 | 243 | 232 | 229 |
| Shares, diluted (weighted) | 167 | 232 | 239 | 242 | 241 | 243 | 232 | 229 |
Balance sheet
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 103 | 160 | 505 | 281 | 95 | 72.1 | 163 | 99 |
| Short-term investments | 43.7 | 319 | 185 | 128 | 0.45 | 0 | ||
| Receivables | 6.38 | 8.86 | 10.9 | 13.8 | 11 | 9.05 | 10.4 | 34.1 |
| Other current assets | 46.5 | 57.5 | 75.9 | 104 | 92.4 | 78.4 | 71.7 | 78.2 |
| Total current assets | 959 | 1,521 | 1,727 | 1,870 | 1,516 | 1,148 | 834 | 702 |
| Property, plant and equipment | 12.7 | 13.9 | 14.5 | 12.5 | 29.1 | 46 | 66.3 | 86.4 |
| Lease right-of-use assets | 14.8 | 13.4 | 62 | 50 | 53.4 | 46.5 | 43.5 | |
| Goodwill | 64.4 | 63.5 | 64.8 | |||||
| Intangible assets | 7.56 | 6.48 | 9.62 | 13.2 | 8.38 | 22.8 | 21 | 18.3 |
| Long-term investments | 32 | 54.5 | 71.6 | 95.5 | 131 | 106 | 60.4 | 42.4 |
| Total assets | 1,034 | 1,633 | 1,902 | 2,080 | 1,906 | 1,820 | 1,311 | 958 |
| Accounts payable | 1.34 | 0.54 | 1.55 | 1.97 | 3.27 | 2.11 | 9.13 | 34 |
| Deferred revenue | 2.1 | 7.32 | 74.5 | 72.1 | 64.6 | 58.1 | 36.4 | 32.6 |
| Total current liabilities | 201 | 351 | 365 | 404 | 319 | 304 | 265 | 247 |
| Lease liabilities | 10.1 | 8.83 | 7.08 | 1.25 | 6.77 | 2.75 | 0.25 | |
| Total liabilities | 213 | 385 | 404 | 431 | 334 | 324 | 276 | 255 |
| Paid-in capital | 1,115 | 1,448 | 1,757 | 1,846 | 1,729 | 1,690 | 1,215 | 925 |
| Retained earnings | -353 | -285 | 289 | 204 | -259 | -289 | -288 | -317 |
| Treasury stock | -29.1 | -14.8 | -18.3 | |||||
| Other comprehensive income | 53.3 | 75.3 | 11.1 | -12 | 84.8 | 107 | 105 | 97 |
| Shareholders' equity | 821 | 1,248 | 1,498 | 1,649 | 1,572 | 1,496 | 1,034 | 704 |
| Total equity | 821 | 1,248 | 1,498 | 1,649 | 1,572 | 1,496 | 1,034 | 704 |
| Total liabilities and equity | 1,034 | 1,633 | 1,902 | 2,080 | 1,906 | 1,820 | 1,311 | 958 |
Cash flow statement
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Net income | -282 | 67.2 | 136 | 91.6 | -70.6 | -28.8 | -6.57 | -16.1 |
| Depreciation and amortization | 3.9 | 6.53 | 8.96 | 7.83 | 6.29 | 6.59 | 5.47 | 5.07 |
| Stock-based compensation | 33 | 40.5 | 62.6 | 45.5 | 22.7 | 11 | 8.84 | 10.5 |
| Deferred income tax | -7.41 | -2.14 | 2.85 | 5.04 | 3.05 | -0.56 | -0.55 | -0.58 |
| Change in receivables | -2.13 | -2.57 | -2 | -2.52 | 1.75 | 0.66 | -1.24 | -23.4 |
| Change in payables | -0.54 | 0.01 | 0.66 | 0.6 | -0.44 | 0.63 | 6.89 | 25.1 |
| Cash from operations | 104 | 279 | 190 | 51.4 | -63.4 | -4.52 | 12.9 | -25.2 |
| Capital expenditures | -10.9 | -8.79 | -8.34 | -6.2 | -22.7 | -17.4 | -25.5 | -24 |
| Acquisitions | -76.9 | -3.94 | ||||||
| Purchases of investments | 0 | |||||||
| Sales and maturities of investments | 1.45 | 87.1 | 0 | 0 | ||||
| Cash from investing | -664 | -529 | 154 | -295 | -123 | 7.5 | 504 | 312 |
| Stock issued | 176 | 3.3 | 40.7 | 1.68 | 0.88 | 0.02 | 0.09 | 0 |
| Share buybacks | -28.5 | -34 | -12.9 | |||||
| Dividends paid | -391 | -344 | ||||||
| Cash from financing | 600 | 306 | 40.7 | 1.68 | 0.88 | -28.5 | -425 | -357 |
| Exchange rate effect | -1.51 | 1.65 | 25.5 | 11 | -13.4 | -1.85 | -1.05 | 1.74 |
| Net change in cash | 40.3 | 56.6 | 385 | -242 | -186 | -25.5 | 91.5 | -69.9 |
| Free cash flow | 93.5 | 271 | 182 | 45.2 | -86.1 | -21.9 | -12.6 | -49.2 |
| Income taxes paid | 12.2 | 28.5 | 15.1 | -12.7 | -1.25 | -1.85 | 0.88 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 13.4% | Gross profit / revenue. |
| Operating margin | -2.5% | Operating income / revenue. |
| EBITDA margin | -2.0% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -1.5% | Pre-tax income / revenue. |
| Net margin | -1.7% | Net income / revenue. |
| FCF margin | -5.3% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | -2.7% | Cash from operations / revenue. |
| Return on equity (ROE) | -1.9% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -1.4% | Net income / average total assets. |
| Return on invested capital (ROIC) | -2.5% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 7.6% | Research and development expense / revenue. |
| Stock-based pay / revenue | 1.1% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 2.6% | Capital expenditures / revenue. |
| D&A / revenue | 0.5% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 11.6% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -11.4% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | -11.1% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 12.5% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 12.1% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | -18.5% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -295.0% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Book value growth, 1y | -32.0% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | -23.5% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | -14.0% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | -26.9% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -20.5% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | -12.8% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | -1.2% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -1.8% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | -0.8% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 2.84x | Current assets / current liabilities. |
| Quick ratio | 0.54x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.40x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 26.6% | Total liabilities / total assets. |
| Working capital | $454.4M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 8.7% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $620.4M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.82x | Revenue / average total assets. |
| Fixed asset turnover | 12.2x | Revenue / average property, plant and equipment. |
| Receivables turnover | 41.8x | Revenue / average receivables. |
| Days sales outstanding | 9 days | 365 x average receivables / revenue. |
| Days payables | 10 days | 365 x average accounts payable / cost of revenue. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$0.07 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | -$0.07 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $4.06 | Revenue / diluted weighted shares. |
| FCF per share | -$0.21 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | -$0.11 | Cash from operations / diluted weighted shares. |
| Book value per share | $3.07 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $2.71 | Tangible book value / shares outstanding. |
| Cash per share | $0.43 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $525.2M | Share price x shares outstanding. |
| Enterprise value | $426.2M | Market cap + total debt - cash - short-term investments. |
| P/S | 0.56x | Market cap / revenue. |
| P/B | 0.75x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 0.85x | Market cap / tangible book value, when positive. |
| EV/Sales | 0.46x | Enterprise value / revenue. |
| FCF yield | -9.4% | Free cash flow / market cap. |
| Earnings yield | -3.1% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 65.6% | Dividends paid over the period / market cap. |
| Shareholder yield | 68.0% | (Dividends paid + share buybacks) / market cap. |
What was HUYA Inc.'s revenue in fiscal 2025?
HUYA Inc. reported revenue of $929.8M for fiscal 2025, 11.6% higher than the year before.
Was HUYA Inc. profitable in fiscal 2025?
No. It reported a net loss of $16.1M.
How much free cash flow did HUYA Inc. generate in fiscal 2025?
Cash from operations of $25.2M minus capital expenditures of $24.0M left free cash flow of -$49.2M.